|
|
|
03 Jul 2008 |
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP
|
|
03 Jul 2008 |
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
|
|
01 Jul 2008 |
Teva Receives First U.S. Approval For Generic Risperdal(R) Tablets; Commences Commercial Launch
|
|
01 Jul 2008 |
Janssen Announces Launch of Authorized Generic for RISPERDAL(R)
|
|
30 Jun 2008 |
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
|
|
25 Jun 2008 |
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hidrochloride Tablets
|
|
24 Jun 2008 |
Bayer concludes supply and licensing agreements for Yasmin(R) and YAZ(R) with Barr for the United States
|
|
23 Jun 2008 |
Taro Receives Final FDA Approval for RX Cetirizine Hydrochloride Syrup ANDA
|
|
16 Jun 2008 |
Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
|
|
16 Jun 2008 |
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
|
|
12 Jun 2008 |
Teva Announces Tentative Approval of Generic Diovan(R) Tablets
|
|
10 Jun 2008 |
Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
|
|
10 Jun 2008 |
Mylan Announces Final FDA Approval for Zaleplon Capsules
|
|
10 Jun 2008 |
Aurobindo Pharma receives final approval for Zaleplon Capsules
|
|
04 Jun 2008 |
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
|
|
03 Jun 2008 |
Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
|
|
30 May 2008 |
Glenmark Generics receives three ANDA approvals
|
|
27 May 2008 |
Aurobindo Pharma receives final approval for Benazepril Hydrochloride Tablets
|
|
23 May 2008 |
SciGen Secures Approval of SciLin(TM), its Recombinant Human Insulin in the Peoples Republic of China
|
|
21 May 2008 |
Teva Announces Approval of Generic Sarafem(R) Pulvules(R)
|
|
15 May 2008 |
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
|
|
14 May 2008 |
Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
|
|
12 May 2008 |
Barr Announces Approval of Generic Yasmin(R)
|
|
09 May 2008 |
Spectrum Pharmaceuticals Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.
|
|
09 May 2008 |
FDA Approves First Generic Ropinirole
|
|
07 May 2008 |
Par Pharmaceutical acquires Spectrum Pharmaceutical's interest in Sumatriptan Injection
|
|
07 May 2008 |
Mylan Announces Final FDA Approval for Ropinirole Hydrochloride TabletsMylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
|
|
02 May 2008 |
Biosimilar G-CSF: Cooperation on Three Continents.
|
|
29 Apr 2008 |
Mylan Announces Final FDA Approval for Trandolapril Tablets
|
|
29 Apr 2008 |
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
|
|
28 Apr 2008 |
Teva Announces Approval Of Generic Flolan(R) For Injection
|
|
25 Apr 2008 |
Ranbaxy Receives Final US FDA Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
|
|
24 Apr 2008 |
Watson Files FDA Application for Generic FENTORA(R)
|
|
24 Apr 2008 |
Akorn-Strides, LLC Announces FDA Approvals for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials
|
|
22 Apr 2008 |
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
|
|
22 Apr 2008 |
Taro Receives Final FDA Approval for Cetirizine Hydrochloride Oral Solution ANDA
|
|
21 Apr 2008 |
Watson Files FDA Application for Generic YASMIN(R)
|
|
21 Apr 2008 |
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
|
|
18 Apr 2008 |
Teva Announces Tentative Approval of Generic Evista(R) Tablets
|
|
17 Apr 2008 |
IMPAX Reports FDA Finding That Budeprion XL(R) 300 mg Is Safe and Effective
|
|
17 Apr 2008 |
Teva Announces Tentative Approval of Generic Maxalt(R) Tablets
|
|
16 Apr 2008 |
Cytokinetics Announces Data Relating to GSK-923295 Presented at the 2008 American Association of Cancer Research Annual Meeting
|
|
16 Apr 2008 |
Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
|
|
14 Apr 2008 |
Oramed Pharmaceuticals Commences Phase 2A Clinical Trials in Israel
|
|
08 Apr 2008 |
Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorisation from MHLW
|
|
04 Apr 2008 |
Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
|
|
03 Apr 2008 |
Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
|
|
03 Apr 2008 |
Ranbaxy launches worlds first bio-generic recombinant injectible for the treatment of osteoporosis in India
|
|
28 Mar 2008 |
NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
|
|
25 Mar 2008 |
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
|
| |
|
Results 1 - 50 of 401 |
